|
1
|
Merika M and Orkin SH: DNA-binding
specificity of GATA family transcription factors. Mol Cell Biol.
13:3999–4010. 1993.PubMed/NCBI
|
|
2
|
Joulin V, Bories D, Eleouet JF, Labastie
MC, Chretien S, Mattei MG and Romeo PH: A T-cell specific TCR delta
DNA binding protein is a member of the human GATA family. EMBO J.
10:1809–1816. 1991.PubMed/NCBI
|
|
3
|
Asselin-Labat ML, Sutherland KD, Barker H,
et al: Gata-3 is an essential regulator of mammary-gland
morphogenesis and luminal-cell differentiation. Nat Cell Biol.
9:201–209. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lim KC, Lakshmanan G, Crawford SE, Gu Y,
Grosveld F and Engel JD: Gata3 loss leads to embryonic lethality
due to noradrenaline deficiency of the sympathetic nervous system.
Nat Genet. 25:209–212. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Grigorieva IV, Mirczuk S, Gaynor KU, et
al: Gata3-deficient mice develop parathyroid abnormalities due to
dysregulation of the parathyroid-specific transcription factor
Gcm2. J Clin Invest. 120:2144–2155. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grote D, Souabni A, Busslinger M and
Bouchard M: Pax 2/8-regulated Gata 3 expression is necessary for
morphogenesis and guidance of the nephric duct in the developing
kidney. Development. 133:53–61. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
van der Wees J, van Looij MA, de Ruiter
MM, et al: Hearing loss following Gata3 haploinsufficiency is
caused by cochlear disorder. Neurobiol Dis. 16:169–178.
2004.PubMed/NCBI
|
|
8
|
Kaufman CK, Zhou P, Pasolli HA, et al:
GATA-3: an unexpected regulator of cell lineage determination in
skin. Genes Dev. 17:2108–2122. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ting CN, Olson MC, Barton KP and Leiden
JM: Transcription factor GATA-3 is required for development of the
T-cell lineage. Nature. 384:474–478. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kouros-Mehr H, Slorach EM, Sternlicht MD
and Werb Z: GATA-3 maintains the differentiation of the luminal
cell fate in the mammary gland. Cell. 127:1041–1055. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Voduc D, Cheang M and Nielsen T: GATA-3
expression in breast cancer has a strong association with estrogen
receptor but lacks independent prognostic value. Cancer Epidemiol
Biomarkers Prev. 17:365–373. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Parikh P, Palazzo JP, Rose LJ, Daskalakis
C and Weigel RJ: GATA-3 expression as a predictor of hormone
response in breast cancer. J Am Coll Surg. 200:705–710. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fang SH, Chen Y and Weigel RJ: GATA-3 as a
marker of hormone response in breast cancer. J Surg Res.
157:290–295. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bong PN, Zakaria Z, Muhammad R, et al:
Expression and mutational analysis of GATA3 in Malaysian breast
carcinomas. Malays J Pathol. 32:117–122. 2010.PubMed/NCBI
|
|
15
|
Mehra R, Varambally S, Ding L, et al:
Identification of GATA3 as a breast cancer prognostic marker by
global gene expression meta-analysis. Cancer Res. 65:11259–11264.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar
|
|
17
|
Chou J, Lin JH, Brenot A, Kim JW, Provot S
and Werb Z: GATA3 suppresses metastasis and modulates the tumour
microenvironment by regulating microRNA-29b expression. Nat Cell
Biol. 15:201–213. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Holm K, Melum E, Franke A and Karlsen TH:
SNPexp - A web tool for calculating and visualizing correlation
between HapMap genotypes and gene expression levels. BMC
Bioinformatics. 11:6002010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Stranger BE, Forrest MS, Dunning M, et al:
Relative impact of nucleotide and copy number variation on gene
expression phenotypes. Science. 315:848–853. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
International HapMap Consortium. The
International HapMap Project. Nature. 426:789–796. 2003. View Article : Google Scholar
|
|
21
|
Usary J, Llaca V, Karaca G, et al:
Mutation of GATA3 in human breast tumors. Oncogene. 23:7669–7678.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Banerji S, Cibulskis K, Rangel-Escareno C,
et al: Sequence analysis of mutations and translocations across
breast cancer subtypes. Nature. 486:405–409. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gaynor KU, Grigorieva IV, Allen MD, et al:
GATA3 mutations found in breast cancers may be associated with
aberrant nuclear localization, reduced transactivation and cell
invasiveness. Horm Cancer. 4:123–139. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bockhorn J, Dalton R, Nwachukwu C, et al:
MicroRNA-30c inhibits human breast tumour chemotherapy resistance
by regulating TWF1 and IL-11. Nat Commun. 4:13932013. View Article : Google Scholar : PubMed/NCBI
|
